David A. Griffith,Robert L. Dow,Scott W. Bagley,Aaron Smith
申请号:
US14497396
公开号:
US08993586B2
申请日:
2014.09.26
申请国别(地区):
US
年份:
2015
代理人:
摘要:
The invention provides a compound of Formula (I)or a pharmaceutically acceptable salt thereof; whereinG isR1, R2 and R3 are as described herein; pharmaceutical compositions thereof; and the use thereof in treating diseases, conditions or disorders modulated by the inhibition of an acetyl-CoA carboxylase enzyme(s) in an animal.